Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,456
Closed -$204K 390
2022
Q3
$204K Buy
+5,456
New +$241K 0.01% 359
2019
Q4
Sell
-8,091
Closed -$279K 243
2019
Q3
$279K Buy
8,091
+98
+1% +$3.29K 0.02% 194
2019
Q2
$273K Buy
+7,993
New +$282K 0.02% 199

Other funds holding EXC

GW & Wade's EXC Position: Q4 2022 in Review

GW & Wade sold out of Exelon (EXC) in Q4 2022, closing a stake of 5,456 shares — an estimated $204K sold.

GW & Wade first reported a position in EXC in Q2 2019 and held it in 3 quarters. The position peaked at $279K in Q3 2019. 1,005 funds tracked by Wall St. Rank hold EXC as of Q4 2022.

  • GW & Wade reported no remaining Exelon position as of Q4 2022 after selling out during the quarter.
  • GW & Wade sold 5,456 Exelon shares in Q4 2022, an estimated $204K.
  • GW & Wade first reported a position in Exelon in Q2 2019 and held it in 3 quarters.
  • GW & Wade's Exelon position peaked at $279K in Q3 2019.
  • 1,005 funds tracked by Wall St. Rank held Exelon as of Q4 2022.

Based on GW & Wade's 13F filing for Q4 2022, filed 10 Feb 2023.